🇮🇳IN
Sign In
FR

FREDUN

NSE

Fredun Pharmaceuticals Ltd

₹1,368.40

-22.60(-1.62%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

FREDUN financial summary

For Mar 2026, Fredun Pharmaceuticals Ltd reported revenue of ₹635 crore, which grew 39.9% from the previous year. Net profit was ₹33 crore, which grew 57.1% year on year, on an operating margin of 14%. Earnings per share came in at ₹20.25. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.

Revenue₹635 crore
Net profit₹33 crore
Operating margin14%
EPS₹20.25

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer